April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Corneal Graft Rejection in the Inbred NIH Minipig
Author Affiliations & Notes
  • S. M. Nicholls
    Clinical Science at South Bristol,
    University of Bristol, Bristol, United Kingdom
  • L. K. Mitchard
    Clinical Veterinary Science,
    University of Bristol, Bristol, United Kingdom
  • J. C. Murrell
    Companion Animal Studies,
    University of Bristol, Bristol, United Kingdom
  • R. Harley
    Clinical Veterinary Science,
    University of Bristol, Bristol, United Kingdom
  • M. Bailey
    Clinical Veterinary Science,
    University of Bristol, Bristol, United Kingdom
  • A. D. Dick
    Clinical Science at South Bristol,
    University of Bristol, Bristol, United Kingdom
  • Footnotes
    Commercial Relationships  S.M. Nicholls, None; L.K. Mitchard, None; J.C. Murrell, None; R. Harley, None; M. Bailey, None; A.D. Dick, None.
  • Footnotes
    Support  Medical Research Council, UK
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1547. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. M. Nicholls, L. K. Mitchard, J. C. Murrell, R. Harley, M. Bailey, A. D. Dick; Corneal Graft Rejection in the Inbred NIH Minipig. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1547. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To develop a pre-clinical model of corneal graft rejection in the semi-inbred NIH minipig and to validate the model clinically, by immunohistology and by assessment of the capacity of corneal endothelium to proliferate in vivo.

Methods: : Corneas of swine leukocyte antigen (SLA)dd strain or SLAcc strain were transplanted to SLAcc strain recipients aged 3-5 months. SLAcc autografts were performed as controls. No immunosuppression was administered. Grafts undergoing rejection, non-rejected grafts and contralateral corneas were excised post-mortem, frozen and sectioned for immunofluorescence histology. Infiltrating antigen presenting cells (CD14+, CD16+, CD163+, MHC class II+), T cells (CD3+, CD4+, CD8+) and ingress of blood vessel were quantified by digital capture of 3-colour-channel images. Numbers of positive pixels for each fluorochrome were counted using ImageJ software, percentage areas of labeling were calculated and analyzed by factorial ANOVA. Excised corneas from non-transplanted pigs were subjected to aseptic freezing injury and cultured in vitro to monitor wound repair. Grafts of some minipigs were monitored for up to 30 days after rejection to determine whether opacity and edema resolved.

Results: : Post-operative complications were minimal. Initial post-transplant edema cleared within 7-10 days. Autografts (n=5) and SLAcc to SLAcc allografts (minor mismatches, n=5) remained clear thereafter. Rejection of SLAdd allografts in SLAcc recipients (MHC and minor mismatches, n=10) was characterized by graft opacity and edema, an epithelial rejection line and neovascularization to the centre of the graft. Median graft survival was 57 days (range 30->90 days). There was a significant increase in leukocyte subsets in transplanted vs contralateral eyes (p<0.001) and in clinically rejected compared with non-rejected grafts (p<0.001). In vitro wound repair of injured corneas was minimal over an 8-day period. Ki67 labeling of scattered endothelial cells (<50 per cornea), indicative of cell division, was evident after 2 days, whether or not corneas had been injured. However, confocal imaging indicated that such cells were detached from the endothelial cell layer. Grafts did not recover clarity in vivo.

Conclusions: : Rejection in the NIH minipig is an excellent pre-clinical model of human rejection. The capacity for corneal endothelial repair in vivo appears to be limited, as in man.

Keywords: transplantation • cornea: endothelium • immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×